This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Friedman JM. Neurofibromatosis 1. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., Editors. Gene Reviews® [Internet]. Seattle, WA, USA: University of Washington, 1993-2016.FriedmanJM.Neurofibromatosis 1PagonRAAdamMPArdingerHHWallaceSEAmemiyaABeanLJHet alSeattle, WA, USAUniversity of Washington19932016Search in Google Scholar
Brosius S. A history of von Recklinghausen’s NF1. J Hist Neurosci. 2010; 19(4): 333-348.BrosiusS.A history of von Recklinghausen’s NF12010194333348Search in Google Scholar
Pasmant E, Parfait B, Luscan A, Goussard P, Briand-Suleau A, Laurendeau I, et al. Neurofibromatosis type 1 molecular diagnosis: What can NGS do for you when you have a large gene with loss of function mutations? Eur J Hum Genet. 2015; 23(5): 596-601.PasmantEParfaitBLuscanAGoussardPBriand-SuleauALaurendeauINeurofibromatosis type 1 molecular diagnosis: What can NGS do for you when you have a large gene with loss of function mutations?2015235596601Search in Google Scholar
Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997; 278(1): 51-57.GutmannDHAylsworthACareyJCKorfBMarksJPyeritzREThe diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2199727815157Search in Google Scholar
Cung W, Freedman LA, Khan NE, Romberg E, Gardner PJ, Bassim CW, et al. Cephalometry in adults and children with neurofibromatosis type 1: Implications for the pathogenesis of sphenoid wing dysplasia and the “NF1 facies.” Eur J Med Genet. 2015; 58(11): 584-590.CungWFreedmanLAKhanNERombergEGardnerPJBassimCWCephalometry in adults and children with neurofibromatosis type 1: Implications for the pathogenesis of sphenoid wing dysplasia and the “NF1 facies.”20155811584590Search in Google Scholar
Sant DW, Margraf RL, Stevenson DA, Grossmann AH, Viskochil DH, Hanson H, et al. Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1. J Med Genet. 2015; 52(4): 256-261.SantDWMargrafRLStevensonDAGrossmannAHViskochilDHHansonHEvaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 12015524256261Search in Google Scholar
Ratner N, Miller SJ. A RASopathy gene commonly mutated in cancer: The neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer. 2015; 15(5): 290-301.RatnerNMillerSJ.A RASopathy gene commonly mutated in cancer: The neurofibromatosis type 1 tumour suppressor2015155290301Search in Google Scholar
Bernier A, Larbrisseau A, Perreault S. Café-au-lait macules and neurofibromatosis type I: A review of the literature. Pediatr Neurol. 2016; 60: 24-29.BernierALarbrisseauAPerreaultS.Café-au-lait macules and neurofibromatosis type I: A review of the literature2016602429Search in Google Scholar
Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: Building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014; 133(1): 1-9.StensonPDMortMBallEVShawKPhillipsACooperDN.The Human Gene Mutation Database: Building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine2014133119Search in Google Scholar
Maruoka R, Takenouchi T, Torii C, Shimizu A, Misu K, Higasa K, et al. The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: A validation study. Genet Test Mol Biomarkers. 2014; 18(11): 722-735.MaruokaRTakenouchiTToriiCShimizuAMisuKHigasaKThe use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: A validation study20141811722735Search in Google Scholar
Zhu L, Zhang Y, Tong H, Shao M, Gu Y, Du X, et al. Clinical and molecular characterization of NF1 patients: Single-center experience of 32 patients from China. Medicine (Baltimore). 2016; 95(10): e3043.ZhuLZhangYTongHShaoMGuYDuXClinical and molecular characterization of NF1 patients: Single-center experience of 32 patients from China20169510e3043Search in Google Scholar
van Minkelen R, van Bever Y, Kromosoeto JN, Withagen-Hermans CJ, Nieuwlaat A, Halley DJ, et al. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in The Netherlands. Clin Genet. 2014; 85(4): 318-327.van MinkelenRvan BeverYKromosoetoJNWithagen-HermansCJNieuwlaatAHalleyDJA clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in The Netherlands2014854318327Search in Google Scholar
Bianchessi D, Morosini S, Saletti V, Ibba MC, Natacci F, Esposito S, et al. 126 novel mutations in Italian patients with neurofibromatosis type 1. Mol Genet Genomic Med. 2015; 3(6): 513-525.BianchessiDMorosiniSSalettiVIbbaMCNatacciFEspositoS126 novel mutations in Italian patients with neurofibromatosis type 1201536513525Search in Google Scholar
Terzi YK, Oguzkan-Balci S, Anlar B, Aysun S, Guran S, Ayter S. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: Importance of genetic counseling. Genet Couns. 2009; 20(2): 195-202.TerziYKOguzkan-BalciSAnlarBAysunSGuranSAyterS.Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: Importance of genetic counseling2009202195202Search in Google Scholar
Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011; 29(1): 24-26.RobinsonJTThorvaldsdóttirHWincklerWGuttmanMLanderESGetzGIntegrative genomics viewer20112912426Search in Google Scholar
Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PE. Improving sequence variant descriptions in mutation databases and literature using the mutalyzer sequence variation nomenclature checker. Hum Mutat. 2008; 29(1): 6-13.WildemanMvan OphuizenEden DunnenJTTaschnerPE.Improving sequence variant descriptions in mutation databases and literature using the mutalyzer sequence variation nomenclature checker2008291613Search in Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405-424.RichardsSAzizNBaleSBickDDasSGastier-FosterJACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology2015175405424Search in Google Scholar
Griffiths S, Thompson P, Frayling I, Upadhyaya M. Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer. 2007; 6(1): 21-34.GriffithsSThompsonPFraylingIUpadhyayaM.Molecular diagnosis of neurofibromatosis type 1: 2 years experience2007612134Search in Google Scholar
Leskelä HV, Kuorilehto T, Risteli J, Koivunen J, Nissinen M, Peltonen S, et al. Congenital pseudarthrosis of neurofibromatosis type 1: Impaired osteoblast differentiation and function and altered NF1 gene expression. Bone. 2009; 44(2): 243-250.LeskeläHVKuorilehtoTRisteliJKoivunenJNissinenMPeltonenSCongenital pseudarthrosis of neurofibromatosis type 1: Impaired osteoblast differentiation and function and altered NF1 gene expression2009442243250Search in Google Scholar
Robinson PN, Buske A, Neumann R, Tinschert S, Nürnberg P. Recurrent 2-bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis. Hum Mutat. 1996; 7(1): 85-88.RobinsonPNBuskeANeumannRTinschertSNürnbergP.Recurrent 2-bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis1996718588Search in Google Scholar
Maynard J, Krawczak M, Upadhyaya M. Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene. Hum Genet. 1997; 99(5): 674-676.MaynardJKrawczakMUpadhyayaM.Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene1997995674676Search in Google Scholar
Upadhyaya M, Maynard J, Osborn M, Harper PS. Six novel mutations in the neurofibromatosis type 1 (NF1) gene. Hum Mutat. 1997; 10(3): 248-250.UpadhyayaMMaynardJOsbornMHarperPS.Six novel mutations in the neurofibromatosis type 1 (NF1) gene1997103248250Search in Google Scholar
Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, et al. A major segment of the neurofi-bromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990; 62(1): 193-201.CawthonRMWeissRXuGFViskochilDCulverMStevensJA major segment of the neurofi-bromatosis type 1 gene: cDNA sequence, genomic structure and point mutations1990621193201Search in Google Scholar
Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, Kücükceylan N, et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet. 2000; 66(3): 790-818.FahsoldRHoffmeyerSMischungCGilleCEhlersCKücükceylanNMinor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain2000663790818Search in Google Scholar
De Luca A, Schirinzi A, Buccino A, Bottillo I, Sinibaldi L, Torrente I, et al. Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1. Hum Mutat. 2004; 23(6): 629-643.De LucaASchirinziABuccinoABottilloISinibaldiLTorrenteINovel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 12004236629643Search in Google Scholar
Abernathy CR, Colman SD, Kousseff BG, Wallace MR. Two NF1 mutations: Frameshift in the GAP-related domain, and loss of two codons toward the 3’ end of the gene. Hum Mutat. 1994; 3(4): 347-352.AbernathyCRColmanSDKousseffBGWallaceMR.Two NF1 mutations: Frameshift in the GAP-related domain, and loss of two codons toward the 3’ end of the gene199434347352Search in Google Scholar
Brems H, Park C, Maertens O, Pemov A, Messiaen L, Upadhyaya M, et al. Glomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association. Cancer Res. 2009; 69(18): 7393-7401.BremsHParkCMaertensOPemovAMessiaenLUpadhyayaMGlomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association2009691873937401Search in Google Scholar
Valero MC, Martín Y, Hernández-Imaz E, Marina Hernández A, Meleán G, Valero AM, et al. A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn. 2011; 13(2): 113-122.ValeroMCMartínYHernández-ImazEMarina HernándezAMeleánGValeroAMA highly sensitive genetic protocol to detect NF1 mutations2011132113122Search in Google Scholar
Böddrich A, Robinson PN, Schülke M, Buske A, Tinschert S, Nürnberg P. New evidence for a mutation hotspot in exon 37 of the NF1 gene. Hum Mutat. 1997; 9(4): 374-377.BöddrichARobinsonPNSchülkeMBuskeATinschertSNürnbergP.New evidence for a mutation hotspot in exon 37 of the NF1 gene199794374377Search in Google Scholar
Ars E, Kruyer H, Morell M, Pros E, Serra E, Ravella A, et al. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet. 2003; 40(6): e82.ArsEKruyerHMorellMProsESerraERavellaARecurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients2003406e82Search in Google Scholar
Terzi YK, Oguzkan S, Anlar B, Aysun S, Ayter S. Neurofibromatosis: Novel and recurrent mutations in Turkish patients. Pediatr Neurol. 2007; 37(6): 421-425.TerziYKOguzkanSAnlarBAysunSAyterS.Neurofibromatosis: Novel and recurrent mutations in Turkish patients2007376421425Search in Google Scholar
Koliou X, Fedonidis C, Kalpachidou T, Mangoura D. Nuclear import mechanism of neurofibromin for localization of the spindle and function in chromosome con-gression. J Neurochem. 2016; 136(1): 78-91.KoliouXFedonidisCKalpachidouTMangouraD.Nuclear import mechanism of neurofibromin for localization of the spindle and function in chromosome con-gression201613617891Search in Google Scholar
Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, et al. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet. 2007; 80(1): 140-151.UpadhyayaMHusonSMDaviesMThomasNChuzhanovaNGiovanniniSAn absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation2007801140151Search in Google Scholar
Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, et al. NF1 microdeletions in neurofi-bromatosis type 1: From genotype to phenotype. Hum Mutat. 2010; 31(6): E1506-E1518.PasmantESabbaghASpurlockGLaurendeauIGrilloEHamelMJNF1 microdeletions in neurofi-bromatosis type 1: From genotype to phenotype2010316E1506E1518Search in Google Scholar
Rad E, Tee AR. Neurofribromatosis type I: Fundamental insights into cell signalling and cancer. Semin Cell Dev Biol. 2016; 52: 39-46.RadETeeAR.Neurofribromatosis type I: Fundamental insights into cell signalling and cancer2016523946Search in Google Scholar